Evidence map›Paper›PMID 2843815›Full record

ArticleNucleic acids research1988

Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia.

D R Collins, T J Knott, R J Pease, L M Powell, S C Wallis, S Robertson, C R Pullinger, R W Milne, Y L Marcel, S E Humphries

Open access · greenAbstract readCase Reports
In one paragraph

Article in Nucleic acids research, 1988. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?Biochimica et biophysica acta. Molecular and cell biology of lipids · 2018
    Review
  5. Human plasma protein N-glycosylation.Glycoconjugate journal · 2016
    Review
  6. Review
  7. Article
  8. Article
  9. A cholesterol-lowering gene maps to chromosome 13q.American journal of human genetics · 2000
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Expression, secretion, and lipid-binding characterization of the N-terminal 17% of apolipoprotein B.Proceedings of the National Academy of Sciences of the United States of America · 1991
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

D R CollinsDivision of Molecular Medicine, MRC Clinical Research Centre, Harrow, UK.
T J Knott
R J Pease
L M Powell
S C Wallis
S Robertson
C R Pullinger
R W Milne
Y L Marcel
S E Humphries
Charing Cross Hospital · GBMontreal Clinical Research Institute · CAMRC Clinical Trials Unit at UCL · GBWake Forest University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial hypobetalipoproteinaemia is a rare autosomal dominant disorder in which levels of apo-B-containing plasma lipoproteins are approximately half-normal in heterozygotes and virtually absent in homozygotes. Here we describe mutations of the apo-B gene that cause two different truncated variants of apo-B in unrelated individuals with hypobetalipoproteinaemia. One variant, apo-B(His1795----Met-Trp-Leu-Val-Thr-Term) is predicted to be 1799 amino acids long and arises from deletion of a single nucleotide (G) from leucine codon 1794. This protein was found at low levels in very low density and low density lipoprotein fractions in the blood. The second, shorter variant, apo-B(Arg1306----Term), is caused by mutation of a CpG dinucleotide in arginine codon 1306 converting it to a stop codon and predicting a protein of 1305 residues. The product of this allele could not be detected in the circulation. The differences in size and behaviour of these two variants compared to apo-B100 or apo-B48 point to domains that may be important for the assembly, secretion or stability of apo-B-containing lipoproteins.

Indexed as

GenesGenetic VariationAmino Acid SequenceApolipoproteins BBase SequenceCholesterolDNADNA Restriction EnzymesFemaleGene AmplificationHomozygoteHumansHypobetalipoproteinemiasHypolipoproteinemiasMaleMolecular Sequence DataApolipoproteins BCholesterolDNADNA Restriction EnzymesTriglycerides

Identifiers

PMID2843815
PMCPMC338564
OpenAlexW2002958822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.